Does pneumococcal conjugate vaccine prevent otitis media?

MOspace/Manakin Repository

Breadcrumbs Navigation

Does pneumococcal conjugate vaccine prevent otitis media?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/11371

[+] show full item record


Title: Does pneumococcal conjugate vaccine prevent otitis media?
Author: Reilly, Philip; Jankowski, Terry Ann, 1951-; Fotinos, Charissa
Keywords: infection prevention
Date: 2011-08
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 60(8) 2011: 488-489.
Abstract: Yes, if the pneumococcal conjugate vaccine (PCV) series is given before 12 months of age. Vaccination before 12 months is associated with a statistically significant reduction in the incidence of both acute (AOM) and recurrent (ROM) otitis media (strength of recommendation [SOR]: A, a systematic review of randomized controlled trials [RCTs] and a large retrospective cohort trial). The benefit disappears if the series is started after 12 months (SOR: B, a systematic review of RCTs with inconsistent results). PCV reduces tympanostomy tube placement for ROM (SOR: A, a large RCT and retrospective cohort trials).
URI: http://hdl.handle.net/10355/11371

This item appears in the following Collection(s)

[+] show full item record